Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year, » Read more about: Massive Upside In Big Money Pharma Favorite? »
Read More
Market Commentary: Did AI Create The Perfect Portfolio?
What stocks would artificial intelligence select to produce outsized returns over the next 20 years?
That’s the question I wanted to ask ChatGPT, the breakthrough AI product from OpenAI, and the results were stunning.
Read More
Market Commentary: Billionaire Buys Gold, Explains Why
In the pantheon of investors, Stanley Druckenmiller is revered as one of the best. When he managed money he had a track record over 30 years of 30% plus returns annually net of fees. Truly a spectacular record.
Read More
Market Commentary: 1 Wildly Undervalued Growth Stock
In 2019, Etsy share price hovered around the $50-60 range. Then the pandemic came in full force and Etsy got swept up with “lockdown era” stocks like Zoom. In a virtual heartbeat, Etsy was trading up at $294 per share by November, 2021.
Read More
1 Cloud SaaS Healthcare Stock to Buy on the Dip?
It might surprise many that Veeva Systems Inc. (NYSE:VEEV), best known for its cloud-based software solutions tailored to the life sciences industry, has maintained a core principle of putting customer success and product excellence ahead of short-term gains.
In a market crowded with SaaS companies seeking to serve a wide variety of enterprises,
» Read more about: 1 Cloud SaaS Healthcare Stock to Buy on the Dip? »
Read MoreThe Ivy
This Airline Just Made a Huge Change, Will It Pay Off for Investors?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation companies. Recently, under pressure to deliver improved value for shareholders and renewed growth, the company announced a slate of changes that could, if successful, increase both its top and bottom lines in the years to come.
Today, let’s take a look at Southwest Airlines to see if LUV is a buy,
» Read more about: This Airline Just Made a Huge Change, Will It Pay Off for Investors? »
Read MoreThe Spotlight
1 Dividend Aristocrat To Be Wary Of
Residential real estate investment trust (REIT) Essex Property Trust, Inc. (NYSE:ESS) operates in West Coast markets, primarily acquiring, developing, and managing multifamily residential properties. It has a portfolio of more than 60,000 apartment units, primarily located in California and Seattle.
Founded in 1971 and going public in 1994,
» Read more about: 1 Dividend Aristocrat To Be Wary Of »
Read MoreThe Daily
“AI can’t be just a bubble…deep investments going into building infrastructure,” says Google exec as company commits $15 billion to data center hub in India